Selenoprotein deficiency and high levels of selenium compounds can effectively inhibit hepatocarcinogenesis in transgenic mice

Sergey V. Novoselov, Diego F. Calvisi, Vyacheslav M. Labunskyy, Valentina M. Factor, Bradley A. Carlson, Dmitri Fomenko, Mohamed E. Moustafa, Dolph L. Hatfield, Vadim N. Gladyshev

Research output: Contribution to journalArticle

89 Citations (Scopus)

Abstract

The micronutrient element selenium (Se) has been shown to be effective in reducing the incidence of cancer in animal models and human clinical trials. Selenoproteins and low molecular weight Se compounds were implicated in the chemopreventive effect, but specific mechanisms are not clear. We examined the role of Se and selenoproteins in liver tumor formation in TGFα/c-Myc transgenic mice, which are characterized by disrupted redox homeostasis and develop liver cancer by 6 months of age. In these mice, both Se deficiency and high levels of Se compounds suppressed hepatocarcinogenesis. In addition, both treatments induced expression of detoxification genes, increased apoptosis and inhibited cell proliferation. Within low-to-optimal levels of dietary Se, tumor formation correlated with expression of most selenoproteins. These data suggest that changes in selenoprotein expression may either suppress or promote tumorigenesis depending on cell type and genotype. Since dietary Se may have opposing effects on cancer, it is important to identify the subjects who will benefit from Se supplementation as well as those who will not.

Original languageEnglish (US)
Pages (from-to)8003-8011
Number of pages9
JournalOncogene
Volume24
Issue number54
DOIs
StatePublished - Dec 1 2005

Fingerprint

Selenium Compounds
Selenoproteins
Selenium
Transgenic Mice
Neoplasms
Micronutrients
Liver Neoplasms
Oxidation-Reduction
Carcinogenesis
Homeostasis
Animal Models
Molecular Weight
Genotype
Cell Proliferation
Clinical Trials
Apoptosis
Gene Expression
Liver
Incidence

Keywords

  • Cancer prevention
  • Redox regulation
  • Selenium
  • Selenocysteine
  • Selenoprotein

ASJC Scopus subject areas

  • Molecular Biology
  • Genetics
  • Cancer Research

Cite this

Novoselov, S. V., Calvisi, D. F., Labunskyy, V. M., Factor, V. M., Carlson, B. A., Fomenko, D., ... Gladyshev, V. N. (2005). Selenoprotein deficiency and high levels of selenium compounds can effectively inhibit hepatocarcinogenesis in transgenic mice. Oncogene, 24(54), 8003-8011. https://doi.org/10.1038/sj.onc.1208940

Selenoprotein deficiency and high levels of selenium compounds can effectively inhibit hepatocarcinogenesis in transgenic mice. / Novoselov, Sergey V.; Calvisi, Diego F.; Labunskyy, Vyacheslav M.; Factor, Valentina M.; Carlson, Bradley A.; Fomenko, Dmitri; Moustafa, Mohamed E.; Hatfield, Dolph L.; Gladyshev, Vadim N.

In: Oncogene, Vol. 24, No. 54, 01.12.2005, p. 8003-8011.

Research output: Contribution to journalArticle

Novoselov, SV, Calvisi, DF, Labunskyy, VM, Factor, VM, Carlson, BA, Fomenko, D, Moustafa, ME, Hatfield, DL & Gladyshev, VN 2005, 'Selenoprotein deficiency and high levels of selenium compounds can effectively inhibit hepatocarcinogenesis in transgenic mice', Oncogene, vol. 24, no. 54, pp. 8003-8011. https://doi.org/10.1038/sj.onc.1208940
Novoselov, Sergey V. ; Calvisi, Diego F. ; Labunskyy, Vyacheslav M. ; Factor, Valentina M. ; Carlson, Bradley A. ; Fomenko, Dmitri ; Moustafa, Mohamed E. ; Hatfield, Dolph L. ; Gladyshev, Vadim N. / Selenoprotein deficiency and high levels of selenium compounds can effectively inhibit hepatocarcinogenesis in transgenic mice. In: Oncogene. 2005 ; Vol. 24, No. 54. pp. 8003-8011.
@article{7b656a55e2184716a61e488a61b39242,
title = "Selenoprotein deficiency and high levels of selenium compounds can effectively inhibit hepatocarcinogenesis in transgenic mice",
abstract = "The micronutrient element selenium (Se) has been shown to be effective in reducing the incidence of cancer in animal models and human clinical trials. Selenoproteins and low molecular weight Se compounds were implicated in the chemopreventive effect, but specific mechanisms are not clear. We examined the role of Se and selenoproteins in liver tumor formation in TGFα/c-Myc transgenic mice, which are characterized by disrupted redox homeostasis and develop liver cancer by 6 months of age. In these mice, both Se deficiency and high levels of Se compounds suppressed hepatocarcinogenesis. In addition, both treatments induced expression of detoxification genes, increased apoptosis and inhibited cell proliferation. Within low-to-optimal levels of dietary Se, tumor formation correlated with expression of most selenoproteins. These data suggest that changes in selenoprotein expression may either suppress or promote tumorigenesis depending on cell type and genotype. Since dietary Se may have opposing effects on cancer, it is important to identify the subjects who will benefit from Se supplementation as well as those who will not.",
keywords = "Cancer prevention, Redox regulation, Selenium, Selenocysteine, Selenoprotein",
author = "Novoselov, {Sergey V.} and Calvisi, {Diego F.} and Labunskyy, {Vyacheslav M.} and Factor, {Valentina M.} and Carlson, {Bradley A.} and Dmitri Fomenko and Moustafa, {Mohamed E.} and Hatfield, {Dolph L.} and Gladyshev, {Vadim N.}",
year = "2005",
month = "12",
day = "1",
doi = "10.1038/sj.onc.1208940",
language = "English (US)",
volume = "24",
pages = "8003--8011",
journal = "Oncogene",
issn = "0950-9232",
publisher = "Nature Publishing Group",
number = "54",

}

TY - JOUR

T1 - Selenoprotein deficiency and high levels of selenium compounds can effectively inhibit hepatocarcinogenesis in transgenic mice

AU - Novoselov, Sergey V.

AU - Calvisi, Diego F.

AU - Labunskyy, Vyacheslav M.

AU - Factor, Valentina M.

AU - Carlson, Bradley A.

AU - Fomenko, Dmitri

AU - Moustafa, Mohamed E.

AU - Hatfield, Dolph L.

AU - Gladyshev, Vadim N.

PY - 2005/12/1

Y1 - 2005/12/1

N2 - The micronutrient element selenium (Se) has been shown to be effective in reducing the incidence of cancer in animal models and human clinical trials. Selenoproteins and low molecular weight Se compounds were implicated in the chemopreventive effect, but specific mechanisms are not clear. We examined the role of Se and selenoproteins in liver tumor formation in TGFα/c-Myc transgenic mice, which are characterized by disrupted redox homeostasis and develop liver cancer by 6 months of age. In these mice, both Se deficiency and high levels of Se compounds suppressed hepatocarcinogenesis. In addition, both treatments induced expression of detoxification genes, increased apoptosis and inhibited cell proliferation. Within low-to-optimal levels of dietary Se, tumor formation correlated with expression of most selenoproteins. These data suggest that changes in selenoprotein expression may either suppress or promote tumorigenesis depending on cell type and genotype. Since dietary Se may have opposing effects on cancer, it is important to identify the subjects who will benefit from Se supplementation as well as those who will not.

AB - The micronutrient element selenium (Se) has been shown to be effective in reducing the incidence of cancer in animal models and human clinical trials. Selenoproteins and low molecular weight Se compounds were implicated in the chemopreventive effect, but specific mechanisms are not clear. We examined the role of Se and selenoproteins in liver tumor formation in TGFα/c-Myc transgenic mice, which are characterized by disrupted redox homeostasis and develop liver cancer by 6 months of age. In these mice, both Se deficiency and high levels of Se compounds suppressed hepatocarcinogenesis. In addition, both treatments induced expression of detoxification genes, increased apoptosis and inhibited cell proliferation. Within low-to-optimal levels of dietary Se, tumor formation correlated with expression of most selenoproteins. These data suggest that changes in selenoprotein expression may either suppress or promote tumorigenesis depending on cell type and genotype. Since dietary Se may have opposing effects on cancer, it is important to identify the subjects who will benefit from Se supplementation as well as those who will not.

KW - Cancer prevention

KW - Redox regulation

KW - Selenium

KW - Selenocysteine

KW - Selenoprotein

UR - http://www.scopus.com/inward/record.url?scp=28544440524&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=28544440524&partnerID=8YFLogxK

U2 - 10.1038/sj.onc.1208940

DO - 10.1038/sj.onc.1208940

M3 - Article

VL - 24

SP - 8003

EP - 8011

JO - Oncogene

JF - Oncogene

SN - 0950-9232

IS - 54

ER -